Immune-related adverse events with bispecific T-cell engager therapy targeting B-cell maturation antigen.
Haematologica
; 109(1): 357-361, 2024 Jan 01.
Article
in En
| MEDLINE
| ID: mdl-37470151
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Bispecific
/
B-Cell Maturation Antigen
Limits:
Humans
Language:
En
Journal:
Haematologica
Year:
2024
Document type:
Article
Country of publication:
Italy